Jiangsu Province has recently launched the "Quality Improvement Program for Enterprise R & D Institutions", which aims to cultivate a number of high-level and high-quality enterprise R & D institutions.

Starting from this year, with three years of hard work, Jiangsu provinve will cultivate about 30 enterprise R & D institutions with international influence and about 200 domestic first-rate enterprise R & D institutions to drive the improvement of enterprise R & D institutions in the province. Lead the formation of a group of innovative leading companies with influence at home and abroad, and drive key industries to enter the mid-to-high end of the global value chain.

"Enterprise R & D Institution Quality Improvement Program".

Recently, the Jiangsu Provincial Joint Conference on Promoting the Construction of Enterprise R & D Institutions released the list of the first batch of incubator banks. With strong R & D capabilities and innovation capabilities of leading industries, Tianjiang Pharmaceutical was selected as an incubator bank.

The Provincial Party Committee and the Provincial Government will support the selected enterprises' R & D institutions to cultivate high-level talent teams, develop high-level core technologies, and build high-quality innovation platforms. At the same time, they will promote the improvement of high-tech R & D institutions by fostering integrated support, social services, and dynamic management.

The selection of the incubation bank indicates that Tianjiang Pharmaceutical's achievements in scientific research and innovation have recognized by the Provincial Party Committee and the Provincial Government. At the same time, it means that Tianjiang Pharmaceutical will enter a higher level in this aspect in the future, the influence in the industry will be further enhanced, and the pace of internationalization will be more firm and powerful ...

"No matter how far we go, we never forget why we started; we will never forget where we are rooted." The future has come, Tianjiang Pharmaceutical must adhere to the high-quality development strategy, constantly explore and innovate, and inject greater momentum into the Chinese medicine formula granule industry!